FDA Suggests Overhaul of Infant Formula Nutrients: No Immediate Impact on WIC Benefits

The U.S. Food and Drug Administration (FDA) has put forth a proposal to revise the nutritional standards for infant formula sold in the nation. Announced on October 29, 2026, and detailed in a document published in the Federal Register on November 2, the FDA intends to adjust the levels of four specific nutrients while leaving others unchanged. This marks the initial step in a broader overhaul of baby feeding standards.

For families, especially those receiving assistance from the WIC program, including Cuban families residing in the U.S., it's crucial to note that this is merely a proposal at this stage. The FDA assures that the current infant formulas on the market remain safe and that this proposal won't immediately affect WIC.

Proposed Nutrient Changes in Infant Formula

The U.S. regulation outlines nutritional criteria for 30 essential nutrients in infant formula. During this preliminary phase, the FDA scrutinized eight of these nutrients and now suggests modifying the parameters for four:

• Iodine: Increase the minimum from 5 to 15 micrograms and reduce the maximum from 75 to 50 micrograms per 100 kilocalories.
• Manganese: Lower the minimum from 5 to 1 microgram per 100 kilocalories and introduce a cap of 50 micrograms.
• Vitamin A: Decrease both minimum and maximum values, adopt a new unit of measure for labeling, and specify that only preformed Vitamin A counts toward the required limits.
• Vitamin D: Raise the minimum from 1 to 2 micrograms and the maximum from 2.5 to 3 micrograms per 100 kilocalories, with updated measurement units.

The FDA finds the existing levels of chloride, potassium, selenium, and sodium satisfactory. Furthermore, it seeks scientific feedback on substances like DHA, ARA, and L-carnitine, which some manufacturers already include. At this stage, there's no proposal to add or remove any nutrients from the mandatory list of 30.

Current Safety of Infant Formula

The FDA explicitly states that the infant formulas currently available are safe. The review isn't triggered by a safety issue but aims to align standards with the latest nutritional and developmental knowledge. The announcement is neither a health warning nor a directive to withdraw brands or batches. Families aren't required to switch formulas, adjust preparation amounts, or add supplements. If a baby requires a special diet or there's a product concern, consulting with a pediatrician is recommended.

Impact on WIC and Families

The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) offers nutritional support to eligible families, including infant formula based on participant needs and program guidelines. The FDA's proposal won't immediately affect WIC. It has committed to collaborating with the USDA, which oversees the program, to assess potential impacts before finalizing any rule.

Thus, the announcement doesn't alter benefits or necessitate an immediate change in the formula provided through WIC. Participants should refer to their state's WIC agency for guidance on available products. The USDA explains how infant formula provision functions within WIC.

Timeline for New Nutritional Regulations

The proposal was officially released on October 29, with a formal publication on November 2, 2026. A public comment period is now open, but a definitive date for implementing new nutritional requirements hasn't been set. The FDA plans to review all 30 required nutrients in three phases, consolidating approved changes into a single regulation. The proposed rule would become effective 60 days post-publication, with manufacturers given three additional years to reformulate and update labeling. These timelines are procedural, not immediate mandates.

Interested parties can review the Federal Register filing and current comment submission guidelines. It's crucial to differentiate between proposing a rule and adopting a final one.

A Nutritional Review, Not a Supply Crisis

This is the first comprehensive review of infant formula nutrient requirements since 1998. Unlike the 2022 formula shortage in the U.S., reported by CiberCuba, the current focus is on nutritional specifications and labeling. The FDA emphasizes it will monitor the supply chain during any transition to prevent disruptions.

For now, families can rest assured that the formulas available remain FDA-approved as safe, WIC benefits remain unchanged due to this proposal, and any mandatory changes for manufacturers will depend on future regulatory decisions.